MedTrace Logo

Study of a Postpartum Diabetes Prevention Program for Hispanic Women

NCT01679210 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 263

Last updated 2020-04-29

No results posted yet for this study

Summary

The overall goal of this randomized controlled trial is to test the efficacy of a culturally and linguistically modified, individually-tailored lifestyle intervention to reduce risk factors for type 2 diabetes and cardiovascular disease among postpartum Hispanic women with a history of abnormal glucose tolerance during pregnancy.

Conditions

Interventions

BEHAVIORAL

Lifestyle Intervention

Stage-matched physical activity and diet intervention materials and health education.

Sponsors & Collaborators

  • University of California, San Diego

    collaborator OTHER

  • Northeastern University

    collaborator OTHER

  • Baystate Medical Center

    collaborator OTHER

  • University of Massachusetts, Worcester

    collaborator OTHER

  • University of Massachusetts, Amherst

    lead OTHER

Principal Investigators

  • Lisa Chasan-Taber, ScD · University of Massachusetts, Amherst

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2018-06-30
Completion
2018-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01679210 on ClinicalTrials.gov